StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.82+0.34 (+22.97%)

Close on Nov 18, 2026Market cap $107.80MP/E –Yield –

Adagene revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $7.67M, up 7332.8% from the year before. The highest annual figure on record is $18.11M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.67M+7332.8%
FY2024Dec 31, 2024$103.20K-99.4%
FY2023Dec 31, 2023$18.11M+94.9%
FY2022Dec 31, 2022$9.29M-8.7%
FY2021Dec 31, 2021$10.18M+1351.7%
FY2020Dec 31, 2020$700.91K+46.0%
FY2019Dec 31, 2019$480.00K-68.2%
FY2018Dec 31, 2018$1.51M–

More Adagene figures

See a number that looks wrong?